Poly(ADP-ribose) polymerase-1 in the nervous system

Neurobiology of Disease

Volumn 7, Issue 4, 2000, Pages 225-239

  Ha, Hyo Chol ^a   Snyder, Solomon H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; DEGENERATIVE DISEASE; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0033830186     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2000.0324     Document Type: Review

References (131)

1. Cloning and expression of cDNA for human poly(ADP-ribose) polymerase
2. Poly(ADP-ribose) catabolism in mammalian cells exposed to DNA-damaging agents
3. Regulatory mechanisms of poly-(ADP-ribose) polymerase
4. PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase
5. Mechanisms of endothelial cell ATP depletion after oxidant injury
6. Effect of L-NAME, an inhibitor of nitric oxidesynthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock
7. Higher plants possess two structurally different poly(ADP-ribose) polymerases
8. Mechanisms of excitotoxicity in neurologic diseases
9. Role of excitotoxicity in human neurological disease
10. Poly(ADP-ribose) in the cellular response to DNA damage
11. Metabolic consequences of DNA damage: DNA damage induces alterations in glucose metabolism by activation of poly (ADP-ribose) polymerase
12. pADPRT-2: A novel mammalian polymerizing (ADP-ribosyl) transferase gene related to truncated pADPRT homologues in plants and Caenorhabditis elegans
13. Role of Poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis: Caspase 3-resistant parp mutant increases rates of apoptosis in transfected cells
14. Inhibitors of the activity of poly (ADP-ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts
15. Localization of nitric oxide synthase indicating a neural role for nitric oxide
16. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum
17. Protection of islet cells from inflammatory cell death in vitro
18. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin
19. DNA strand breaks, NAD metabolism, and programmed cell death
20. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme
21. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity
22. Poly(ADP-ribose) polymerase: A guardian of the genome that facilitates DNA repair by protecting against DNA recombination
23. cDNA sequence, protein structure, and chromosomal location of the human gene for poly(ADP-ribose) polymerase
24. Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice
25. Poly(ADP-ribose) polymerase: Early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells
26. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
27. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
28. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice
29. Modulation of chromatin superstructure induced by poly(ADP-ribose) synthesis and degradation
30. Poly(ADP-ribose) polymerase: A molecular nick-sensor
31. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells
32. The role of excitotoxicity in neurodegenerative disease: Implications for therapy
33. Intracellular ATP levels determine cell death fate by apoptosis or necrosis
34. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage
35. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
36. The use of nicotinamide in the prevention of type 1 diabetes
37. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase
38. Elevation of cyclic GMP levels in central nervous system by excitatory and inhibitory amino acids
39. Poly(ADP-ribosyl)ation of chromatin: Kinetics of relaxation and its effect on chromatin solubility
40. Molecular mechanisms of beta-cell destruction in IDDM: The role of nicotinamide
41. Theory and practice of nicotinamide trials in pre-type 1 diabetes
42. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices
43. NO in septic shock: Good, bad or ugly? Learning from iNOS knockouts
44. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion
45. Survival and proliferation of cells expressing caspase-uncleavable poly(ADP-ribose) polymerase in response to death-inducing DNA damage by an alkylating agent
46. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion
47. Purification and characterization of poly(ADP-ribose) glycohydrolase: Different modes of action on large and small poly(ADP-ribose)
48. Analysis of oxygen radical toxicity in pancreatic islets at the single cell level
49. Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells
50. Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis
51. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase
52. Nitric oxide: A neural messenger
53. A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues
54. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis
55. An alternative form of poly-(ADP-ribose) polymerase in Drosophila melanogaster and its ectopic expression in rat-1 cells
56. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
57. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase
58. Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock
59. ADP-ribosylation of ADPR-transferase and topoisomerase I in intact mouse epidermal cells JB6
60. Poly(ADP-ribosylation) of histones in intact human keratinocytes
61. The oxygen free radical system: From equations through membrane-protein interactions to cardiovascular injury and protection
62. Primary structure of human poly(ADP-ribose) synthetase as deduced from cDNA sequence
63. The effect of 3-aminobenzamide, an inhibitor of poly-ADP-ribose polymerase, on ischemia/perfusion damage in rat retina
64. Molecular and biochemical features of poly (ADP-ribose) metabolism
65. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
66. Oxidative stress inhibits apoptosis in human lymphoma cells
67. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis
68. Apoptosis in the absence of poly-(ADP-ribose) polymerase
69. Isolation and characterization of the cDNA encoding bovine poly(ADP-ribose) glycohydrolase
70. Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzhemeir's disease
71. Neuronal accumulation of poly(ADP-ribose) after brain ischaemia
72. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon gamma and lipopolysaccharide
73. Immunoquantitation and size determination of intrinsic poly(ADP-ribose) polymerase from acid precipitates: An analysis of the in vivo status in mammalian species and in lower eukaryotes
74. Purification and cDNA cloning of maize Poly(ADP)-ribose polymerase
75. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism
76. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes
77. Poly(ADP-ribose) polymerase: A novel finger protein
78. Splitting of the ribose-ribose linkage of poly(adenosine diphosphate-robose) by a calf thymus extract
79. Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis
80. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
81. Time course of polynucleosome relaxation and ADP-ribosylation: Correlation between relaxation and histone H1 hyper-ADP-ribosylation
82. Poly(ADP-ribosyl)ation of DNA polymerase beta in vitro
83. Poly(ADP-ribose) and the response of cells to ionizing radiation
84. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis: Lesson from an uncleavable mutant
85. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice
86. Cell death during development of the nervous system
87. Nitric oxide: A key mediator in sepsis and endotoxaemia?
88. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes
89. Poly (ADP-ribose) polymerase, nitric oxide and cell death
90. Myocardial postischemic injury is reduced by polyADPribose polymerase-1 gene disruption
91. Aurintricarboxylic acid protects hippocampal neurons from NMDA- and ischemia-induced toxicity in vivo
92. Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken
93. Stimulation of the DNA-dependent protein kinase by poly(ADP-ribose) polymerase
94. Characterization of sPARP-1
95. Nitric oxide synthase in models of focal ischemia
96. The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity
97. ADP-ribosylation of nonhistone proteins in HeLa cells: Modification of DNA topoisomerase II
98. Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers
99. Poly(ADP-ribose) polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in DNA-damaged cells: Mechanism of stimulation of unscheduled DNA synthesis
100. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres
101. Role of nitric oxide in the autonomic innervation of smooth muscle
102. Mechanisms and genes of cellular suicide
103. Endothelial dysfunction in a rat model of endotoxic shock: Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite
104. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion
105. Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects
106. Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite
107. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia
108. Endogenous ADP ribosylation of high mobility group proteins 1 and 2 and histone H1 following DNA damage in intact cells
109. Apoptosis in the pathogenesis and treatment of disease
110. Caspases: Enemies within
111. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain
112. Mouse mammary tumor virus gene expression is suppressed by oligomeric ellagitannins, novel inhibitors of poly(ADP-ribose) glycohydrolase
113. Nucleotide sequence of a full-length cDNA for human fibroblast poly(ADP-ribose) polymerase
114. Peroxynitrite-induced thymocyte apoptosis: The role of caspases and poly (ADP-ribose) synthetase (PARS) activation
115. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: Evidence for peroxynitrite-mediated reperfusion injury
116. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease
117. PARP is important for genomic stability but dispensable in apoptosis
118. ADP-ribosylation of p53 tumor suppressor protein: Mutant but not wild-type p53 is modified
119. ADP-ribosylation of wild-type p53 in vitro: Binding of p53 protein to specific p53 consensus sequence prevents its modification
120. Cell death: The significance of apoptosis
121. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets
122. Characterization of human poly(ADP-ribose) polymerase with autoantibodies
123. Inhibition of DNA polymerase alpha, DNA polymerase beta, terminal deoxynucleotidyl transferase, and DNA ligase II by poly-(ADP-ribosyl)ation reaction in vitro
124. A shuttle mechanism for DNA-protein interactions: The regulation of poly(ADP-ribose) polymerase
125. Targeted gene deletion of heme oxygenase 2 reveals neural role for carbon monoxide
126. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity
127. Poly(ADP-ribose) synthetase activation: An early indicator of neurotoxic DNA damage
128. Structure of an XRCC1 BRCT domain: A new protein-protein interaction module
129. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase
130. Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury
131. Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis